Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages. To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDR(low)/C-KIT(CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR(low)/C-KIT(neg) cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDR(low)/C-KIT(neg) fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colony-forming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMs can reliably be derived from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) using protocols that involve timed application of GFs or small molecules, that are designed to recapitulate developmental pathways.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [148]
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S. L., Chen, J., & Evans, S. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00363-0 · Cited by 1,610
Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.029 · Cited by 1,038
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., LeCapitaine, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706760104 · Cited by 980
Requirement for Wnt3 in vertebrate axis formation
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999) · Nature Genetics · doi:10.1038/11932 · Cited by 901
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., & Harvey, R. P. (1993) · Development · doi:10.1242/dev.119.2.419 · Cited by 861
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B., & Robertson, E. J. (1994) · Development · doi:10.1242/dev.120.7.1919 · Cited by 770
Kattman, S. J., Huber, T. L., & Keller, G. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.002 · Cited by 729
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
Cited by
Items 401–500 of 1,000
Smarcd3b and Gata5 promote a cardiac progenitor fate in the zebrafish embryo
Lou, X., Deshwar, A. R., Crump, J. G., & Scott, I. C. (2011) · Development · doi:10.1242/dev.064279 · Cited by 60
“Cells with CPC characteristics have been isolated from the developing mouse embryo, differentiating embryonic stem (ES) cells and adult hearts (Bu et al., 2009; Kattman et al., 2006; Moretti et al., 2006; Yang et al., 2008).”
BackgroundCardiac Regeneration using Human Embryonic Stem Cells: Producing Cells for Future Therapy
Wong, S. S. Y., & Bernstein, H. S. (2010) · Regenerative Medicine · doi:10.2217/rme.10.52 · Cited by 60
Efficient Differentiation of Human Pluripotent Stem Cells to Endothelial Cells
Gu, M. (2018) · Current Protocols in Human Genetics · doi:10.1002/cphg.64 · Cited by 65
“…the marker for cardiac and hematoendothelial progenitors (Kattman, Huber, & Keller, 2006; Kennedy, D’Souza, Lynch-Kattman, Schwantz, & Keller, 2007; Yang et al., 2008), CD34 as the marker for endothelial progenitor cells (Cheng et al., 2013), and CD144 as the marker for mature endothelial cells…”
BackgroundCardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials
Barreto, S., Hamel, L., Schiatti, T., Yang, Y., & George, V. T. (2019) · Cells · doi:10.3390/cells8121536 · Cited by 64
“Such factors included Activin A, BMP2/4 and FGF2 which induce cardiac mesoderm formation in iPSCs [15,29,122,128,129].”
BackgroundThe Role of Tissue Engineering and Biomaterials in Cardiac Regenerative Medicine
Zhao, Y., Feric, N. T., Thavandiran, N., Nunes, S. S., & Radisic, M. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.08.027 · Cited by 63
“These molecules are applied to iPSCs or ESCs grown in embryoid body format (7, 8) or in monolayers (9).”
BackgroundMoon, S., Kang, S., Park, S., Bae, D., Kim, S. J., Lee, H.-A., Kim, K. S., Hong, K.-S., Kim, J. S., Tae, J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.022 · Cited by 59
Foo, K. S., Lehtinen, M. L., Leung, C. Y., Lian, X. L., Xu, J., Keung, W., Geng, L., Kolstad, T. R., Thams, S., Wong, A. O.-T., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.012 · Cited by 65
Towards Multi-Organoid Systems for Drug Screening Applications
Miranda, C. C., Fernandes, T. G., Diogo, M. M., & Cabral, J. M. S. (2018) · Bioengineering · doi:10.3390/bioengineering5030049 · Cited by 68
“The first report of derivation of cardiac precursor cells as suspension aggregates under chemically defined conditions was based on the modulation of the Wnt signaling pathway, and employed the use of BMP4, Activin A, FGF2, VEFG and DKK1 to either activate or inhibit this signaling pathway at specific time points [54].”
BackgroundMethodRegenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives
Arjmand, B., Abedi, M., Arabi, M., Alavi-Moghadam, S., Rezaei–Tavirani, M., Hadavandkhani, M., Tayanloo-Beik, A., Kordi, R., Roudsari, P. P., & Larijani, B. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.704903 · Cited by 64
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension
Harvey, L. D., Alotaibi, M., Tai, Y., Tang, Y., Kim, H. J., Kelly, N. J., Sun, W., Woodcock, C.-S. C., Arshad, S., Culley, M. K., et al. (2025) · Science · doi:10.1126/science.adn7277 · Cited by 62
The Potential of Stem Cells for the Restoration of Auditory Function in Humans
Hu, Z., & Ulfendahl, M. (2013) · Regenerative Medicine · doi:10.2217/rme.13.32 · Cited by 61
Tandon, V., Zhang, B., Radisic, M., & Murthy, S. K. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.08.006 · Cited by 62
“Subsequent application of WNT inhibitor DKK1 and KDR ligand VEGF165 significantly enhances the differentiation of KDR+ progenitors into CMs (Kattman et al., 2006; Yang et al., 2008) while bFGF is added to support continued expansion of cardiovascular lineages.”
BackgroundInfluentialLow Oxygen Tension Enhances Endothelial Fate of Human Pluripotent Stem Cells
Kusuma, S., Peijnenburg, E., Patel, P., & Gerecht, S. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303274 · Cited by 53
Engineered Tissue Patch for Cardiac Cell Therapy
Zhang, J. J. (2015) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-015-0399-5 · Cited by 61
Essential and Unexpected Role of Yin Yang 1 to Promote Mesodermal Cardiac Differentiation
Gregoire, S., Karra, R., Passer, D., Deutsch, M.-A., Krane, M., Feistritzer, R., Sturzu, A., Domian, I., Saga, Y., & Wu, S. M. (2013) · Circulation Research · doi:10.1161/circresaha.113.259259 · Cited by 58
Cimetta, E., Sirabella, D., Yeager, K., Davidson, K., Simon, J., Moon, R. T., & Vunjak-Novakovic, G. (2013) · Lab Chip · doi:10.1039/c2lc40836h · Cited by 56
Pearson, S., Cuvertino, S., Fleury, M., Lacaud, G., & Kouskoff, V. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.01.003 · Cited by 63
“Although stem-cell-based regenerative medicine is still a distant goal, outstanding progress has been made in generating and engrafting ESC-derived lineages such as dopamine neurones (Kriks et al., 2011) and cardiomyocytes (Shiba et al., 2012; Yang et al., 2008).”
BackgroundNatural and Synthetic Regulators of Embryonic Stem Cell Cardiogenesis
Willems, E., Bushway, P., & Mercola, M. A. (2009) · Pediatric Cardiology · doi:10.1007/s00246-009-9409-2 · Cited by 61
“conditions for production of cardiomyocytes [26, 41, 43].”
BackgroundInstant spectral assignment for advanced decision tree-driven mass spectrometry
Bailey, D. J., Rose, C. M., McAlister, G. C., Brumbaugh, J., Yu, P., Wenger, C. D., Westphall, M. S., Thomson, J. A., & Coon, J. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205292109 · Cited by 55
Jadon, D. R., Sengupta, R., Nightingale, A. L., Lu, H., Dunphy, J., Green, A. C. A., Elder, J. T., Nair, R. P., Korendowych, E., Lindsay, M. A., et al. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1417-7 · Cited by 57
“In human embryonic stems cells, Dkk-1 plays an important role promoting synovial angiogenesis, that might encourage inflammatory pannus formation, and subsequent erosion [19].”
BackgroundMarchianò, S., Bertero, A., & Murry, C. E. (2019) · Pediatric Cardiology · doi:10.1007/s00246-019-02165-5 · Cited by 59
Endoderm generates endothelial cells during liver development
Goldman, O., Han, S., Hamou, W., Jodon de Villeroche, V., Uzan, G., Lickert, H., & Gouon-Evans, V. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.08.009 · Cited by 56
Pešl, M., Aćimović, I., Přibyl, J., Héžová, R., Vilotić, A., Fauconnier, J., Vrbský, J., Kružliak, P., Skládal, P., Kára, T., et al. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0436-9 · Cited by 56
“EBs [4, 6, 7], the heterogeneity in size and shape of the”
BackgroundRegenerating functional heart tissue for myocardial repair
Alcon, A., Çağavi, E., & Qyang, Y. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0942-4 · Cited by 59
“Some studies have identified the surface protein, Flk-1, that specifically labels cardiac stem cells for FACS purification [100].”
Human embryonic stem cells for cardiomyogenesis
Habib, M., Caspi, O., & Gepstein, L. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.08.008 · Cited by 62
“For example, using the mESC model, Katman et al. [28] and Moretti et al. [29] identified the presence of multipotent Flk-1+ and Isl1+ cardiovascular progenitor cells, respectively, that can give rise to cardiomyocytes, endothelial cells, and vascular smooth muscle lineages.”
BackgroundInfluentialInduced Pluripotent Stem Cell Modeling of Multisystemic, Hereditary Transthyretin Amyloidosis
Leung, A., Nah, S. K., Reid, W., Ebata, A., Koch, C. M., Monti, S., Genereux, J. C., Wiseman, R. L., Wolozin, B., Connors, L. H., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.10.003 · Cited by 54
Zhang, B., Green, J. V., Murthy, S. K., & Radisic, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037619 · Cited by 54
Stem cell engineering for treatment of heart diseases: Potentials and challenges
Li, S. C., Wang, L., Jiang, H., Acevedo, J., Chang, A. C., & Loudon, W. G. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.11.009 · Cited by 59
“When transplanted into ischemically injured myocardium in rats, they differentiate into normal myocardial cells and remained viable at least 4 months (Yang et al., 2008).”
BackgroundA bird's‐eye view of cell therapy and tissue engineering for cardiac regeneration
Soler‐Botija, C., Bagó, J. R., & Bayés‐Genís, A. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06519.x · Cited by 56
Cardiomyocytes derived from human pluripotent stem cells for drug screening
Zeevi‐Levin, N., Itskovitz‐Eldor, J., & Binah, O. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.005 · Cited by 54
Effective clearance of GL‐3 in a human iPSC‐derived cardiomyocyte model of Fabry disease
Itier, J., Ret, G., Viale, S., Sweet, L., Bangari, D. S., Caron, A., Legall, F., Bénichou, B., Leonard, J., Deleuze, J., et al. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9724-5 · Cited by 54
“Cardiac differentiation of human iPSC A 3D protocol of differentiation (adapted from Yang et al. 2008) was used to generate iPSC-derived cardiomyocytes.”
MethodBranco, M. A., Dias, T. P., Cabral, J. M. S., Pinto-do-Ó, P., & Diogo, M. M. (2022) · Nature Communications · doi:10.1038/s41467-022-34730-7 · Cited by 50
Tunneling into Clean Heavy Fermion Compounds: Origin of the Fano Line Shape
Wölfle, P., Dubi, Y., & Balatsky, A. V. (2010) · Physical Review Letters · doi:10.1103/physrevlett.105.246401 · Cited by 62
Dixon, J. E., Dick, E., Rajamohan, D., Shakesheff, K. M., & Denning, C. N. (2011) · Molecular Therapy · doi:10.1038/mt.2011.125 · Cited by 53
Cardiac Stem Cell Therapy for Cardiac Repair
Hong, K. U., & Bolli, R. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0324-3 · Cited by 56
Poon, E., Keung, W., Liang, Y., Ramalingam, R., Yan, B., Zhang, S., Chopra, A., Moore, J., Herren, A., Lieu, D. K., et al. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000918 · Cited by 52
“For cardiac differentiation, growth factors were added at specific stages of differentiation.(20) The following cytokines were used: days 0 to 1, bone morphogenetic protein 4 (0.”
MethodSharma, P., Abbasi, C., Lazic, S., Teng, A. C. T., Wang, D., Dubois, N. C., Ignatchenko, V., Wong, V., Liu, J., Araki, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms9391 · Cited by 56
Self-citationLineage-Specific Differentiation Is Influenced by State of Human Pluripotency
Lee, J., Laronde, S., Collins, T. J., Shapovalova, Z., Tanasijevic, B., McNicol, J. D., Fiebig‐Comyn, A., Benoit, Y. D., Lee, J. B., Mitchell, R. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.036 · Cited by 56
Flk1-GFP BAC Tg Mice: An Animal Model for the Study of Blood Vessel Development
Ishitobi, H., Matsumoto, K., Azami, T., Itoh, F., Susumu, I. T. O. H., Takahashi, S., & Ema, M. (2010) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.59.615 · Cited by 58
“Importantly, these properties have been observed in both mouse and human ES cells in in vitro differentiation models [19].”
BackgroundCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells
Tanaka, A., Yuasa, S., Node, K., & Fukuda, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818894 · Cited by 54
Cardiac progenitors and paracrine mediators in cardiogenesis and heart regeneration
Witman, N., Zhou, C., Beverborg, N. G., Sahara, M., & Chien, K. R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.10.011 · Cited by 55
Liu, F., Fang, Y., Hou, X., Yan, Y., Xiao, H., Zuo, D., Wen, J., Wang, L., Zhou, Z., Dang, X., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01794-5 · Cited by 52
Knarston, I. M., Pachernegg, S., Robevska, G., Ghobrial, I. M., Er, P. X., Georges, E., Takasato, M., Combes, A. N., Jørgensen, A., Little, M. H., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.10.009 · Cited by 67
Microfabrication and microfluidics for muscle tissue models
Uzel, S. G. M., Pavesi, A., & Kamm, R. D. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.08.013 · Cited by 55
“Other researchers selected a cocktail of BMP-4, bFGF, Activin-A, VGEF and DKK-1 to induce cardiogenesis in mouse and human PSC cells (Kattman et al. 2010; L. Yang et al. 2008).”
BackgroundMolecular basis for Flk1 expression in hemato-cardiovascular progenitors in the mouse
Ishitobi, H., Wakamatsu, A., Liu, F., Azami, T., Hamada, M., Matsumoto, K., Kataoka, H., Kobayashi, M., Choi, K., Nishikawa, S.-I., et al. (2011) · Development · doi:10.1242/dev.065565 · Cited by 60
Liu, B., Yeh, H.-Y., Lin, Y., Wang, M.-H., Chen, D. C., Lee, B.-H., & Hsu, S. (2012) · BioResearch open access · doi:10.1089/biores.2012.0285 · Cited by 51
“The addition of exogenous growth factors, such as Activin A and BMP4, further enhanced the embryoid body formation and differentiation of human ESCs into spontaneously beating cells.(21) On the other hand, reprogrammed somatic cells (induced pluripotent stem cells) also formed the embryoid bodies that differentiated i…”
BackgroundStrategies and Challenges to Myocardial Replacement Therapy
Feric, N. T., & Radisic, M. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0288 · Cited by 47
Steps toward Maturation of Embryonic Stem Cell-Derived Cardiomyocytes by Defined Physical Signals
Shen, N., Knopf, A., Westendorf, C., Kraushaar, U., Riedl, J., Bauer, H., Pöschel, S., Layland, S. L., Holeiter, M., Knolle, S., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.04.021 · Cited by 53
“…Lundy et al., 2013; Nunes et al., 2013); however, the PSC-CMs displayed an immature phenotype when compared with adult CMs with respect to sarcomere structure (Yang et al., 2008), calcium-handling properties (Li et al., 2013), and electrophysiology (Blazeski et al., 2012; Ribeiro et al., 2015).”
BackgroundBurridge, P. W., & Zambidis, E. T. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-348-0_12 · Cited by 55
Flexible 3D printed microwires and 3D microelectrodes for heart-on-a-chip engineering
Wu, Q., Zhang, P., O’Leary, G., Zhao, Y., Xu, Y., Rafatian, N., Okhovatian, S., Landau, S., Valiante, T. A., Travaš‐Sejdić, J., et al. (2023) · Biofabrication · doi:10.1088/1758-5090/acd8f4 · Cited by 53
“Human iPSC CMs were obtained from hiPSC line BJ1D (a kind gift from Dr William Stanford) [11] using monolayer differentiation protocols [45, 46].”
MethodConcise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells
Yang, C., Al-Aama, J. Y., Stojković, M., Keavney, B. D., Trafford, A. W., Lako, M., & Armstrong, L. (2015) · Stem Cells · doi:10.1002/stem.2070 · Cited by 55
Stem Cells and Their Derivatives: A Renaissance in Cardiovascular Translational Research
Kattman, S. J., Koonce, C. H., Swanson, B. J., & Anson, B. D. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9235-1 · Cited by 50
“Recent advances have utilized a more directed approach using serum-free media along with specific inducers to direct differentiation into relevant tissues [12, 27, 28].”
BackgroundMethodSelf-citationHuman embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation
Cheung, C., & Sinha, S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.07.014 · Cited by 53
Endothelial Cells Derived From Nuclear Reprogramming
Wong, W. T., Huang, N. F., Botham, C. M., Sayed, N., & Cooke, J. P. (2012) · Circulation Research · doi:10.1161/circresaha.111.247213 · Cited by 52
Modeling human lung development and disease using pluripotent stem cells
Snoeck, H. (2014) · Development · doi:10.1242/dev.115469 · Cited by 53
“Because of the conservation of mechanisms involved in the establishment of the body plan and in organ domain specification, insights from mouse development are the scientific underpinning of this approach (Chambers et al., 2009; D’Amour et al., 2005; Gouon-Evans et al., 2006;Kubo et al., 2004;Nostro andKeller, 2012; P…”
BackgroundMyotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability
Ueki, J., Nakamori, M., Nakamura, M., Nishikawa, M., Yoshida, Y., Tanaka, A., Morizane, A., Kamon, M., Araki, T., Takahashi, M. P., et al. (2017) · Scientific Reports · doi:10.1038/srep42522 · Cited by 50
Revised roles of ISL1 in a hES cell-based model of human heart chamber specification
Quaranta, R., Fell, J., Rühle, F., Rao, J., Piccini, I., Araúzo-Bravo, M. J., Verkerk, A. O., Stoll, M., & Greber, B. (2018) · eLife · doi:10.7554/elife.31706 · Cited by 51
“Moreover, it is conceivable that different differentiation protocols may give rise to distinct differentiation intermediates or mixtures thereof (Lian et al., 2012; Yang et al., 2008; Zhang et al., 2015).”
Hidalgo, A., Glass, N. R., Ovchinnikov, D. A., Yang, S., Zhang, X., Mazzone, S. B., Chen, C., Wolvetang, E. J., & Cooper-White, J. J. (2018) · APL Bioengineering · doi:10.1063/1.5000746 · Cited by 55
Veevers, J., Farah, E. N., Corselli, M., Witty, A. D., Palomares, K., Vidal, J. G., Emre, N., Carson, C. T., Ouyang, K., Liu, C., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.07.007 · Cited by 53
“EBs were differentiated to the cardiovascular lineage as described previously (Yang et al., 2008; Dubois et al., 2011; Kattman et al., 2011), withmodifications as detailed and as shown in Figure S1D.”
BackgroundMethodSelf-citationZheng, W., Li, Q., Zhao, C., Da, Y., Zhang, H., & Chen, Z. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00239 · Cited by 56
“Furthermore, human embryonic stem cells (hESCs) have been demonstrated to differentiate to neurons and glia in a chemically defined culture (Li et al., 2005; Watanabe et al., 2007; Yang et al., 2008).”
BackgroundCoordinate Nodal and BMP inhibition directs Baf60c-dependent cardiomyocyte commitment
Cai, W., Albini, S., Wei, K., Willems, E., Guzzo, R. M., Tsuda, M., Giordani, L., Spiering, S., Kurian, L., Yeo, G. W.-M., et al. (2013) · Genes & Development · doi:10.1101/gad.225144.113 · Cited by 57
“3A,B), as noted previously (Yang et al. 2008; Blin et al. 2010).”
Poon, E., Kong, C.-W., & Li, R. A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2002363 · Cited by 49
Josowitz, R., Lu, J., Falce, C., D’Souza, S. L., Wu, M., Cohen, N., Dubois, N. C., Zhao, Y., Sobie, E. A., Fishman, G. I., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101316 · Cited by 49
Wang, K., Terrenoire, C., Sampson, K. J., Iyer, V., Osteen, J. D., Lu, J. T., Keller, G. M., Kotton, D. N., & Kass, R. S. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.220863 · Cited by 54
“For both hES2 and hiPS cells, cardiac differentiation was induced by systematically staging, in vitro, the events that occur in a developing embryo, by exposing the hESCs and hiPSCs to cytokines using a previously reported procedure (Yang et al. 2008).”
MethodSelf-citationPekkanen-Mattila, M., Pelto‐Huikko, M., Kujala, V. J., Suuronen, R., Skottman, H., Aalto‐Setälä, K., & Kerkelä, E. (2010) · Histochemistry and Cell Biology · doi:10.1007/s00418-010-0689-7 · Cited by 58
“…Tampere, Finland R. Suuronen Department of Eye, Ear and Oral Diseases, Tampere University Hospital, Tampere, Finland K. Aalto-Setälä Heart Center, Tampere University Hospital, Tampere, Finland (END-2) or with defined growth factors (Laflamme et al. 2007; Mummery et al. 2003; Yang et al. 2008).”
BackgroundTitmarsh, D. M., Hudson, J. E., Hidalgo, A., Elefanty, A. G., Stanley, E. G., Wolvetang, E. J., & Cooper-White, J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052405 · Cited by 48
“DKK1 was expressed 13-fold higher in MIXL1-GFP cells than in uninduced cells, in concordance with previous studies showing that positive (WNT3A) and negative (DKK1, SFRPs) extracellular regulators of canonical Wnt signalling are transiently expressed through 3–4 d in hESCs differentiating towards the cardiac lineage […”
ResultPluripotent stem cell derived cardiovascular progenitors – A developmental perspective
Birket, M. J., & Mummery, C. L. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.01.012 · Cited by 47
“…proportion of early Nkx2-5þ cells differentiating from mESCs and to be associated with clonogenicity (Wu et al., 2006), where as in the human system the CPC population is c-kit at day 6 of differentiationwhich is more consistent with lineage tracing data (Van Berlo et al., 2014; Yang et al., 2008).”
BackgroundNotch Inhibition Promotes Human Embryonic Stem Cell-Derived Cardiac Mesoderm Differentiation
Jang, J., Ku, S., Kim, J. E., Choi, K., Kim, Y. Y., Kim, H. S., Oh, S. K., Lee, E. J., Cho, H., Song, Y. H., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1053 · Cited by 49
Systems biology approaches to heart development and congenital heart disease
Sperling, S. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr126 · Cited by 53
Association of telomere shortening in myocardium with heart weight gain and cause of death
Terai, M., Izumiyama-Shimomura, N., Aida, J., Ishikawa, N., Sawabe, M., Arai, T., Fujiwara, M., Ishii, A., Nakamura, K.-I., & Takubo, K. (2013) · Scientific Reports · doi:10.1038/srep02401 · Cited by 46
Cardiogenesis From Human Embryonic Stem Cells - Mechanisms and Applications -
Mignone, J., Kreutziger, K. L., Paige, S. L., & Murry, C. E. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0958 · Cited by 48
Šepac, A., Sedlić, F., Si‐Tayeb, K., Lough, J., Duncan, S. A., Bienengraeber, M., Park, F., Kim, J., & Bosnjak, Z. J. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181eff6b7 · Cited by 49
“Previously published protocols using the same growth factors were modified in this study.(12,37) To be exact, pluripotent cells were exposed to activin-A at a relatively high level (50 ng/ml) for an extended period of time (5 days).”
MethodChen, A., Ting, S., Seow, J., Reuveny, S., & Oh, S. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt401 · Cited by 50
The promise of human embryonic stem cells in aging-associated diseases
Yabut, O., & Bernstein, H. S. (2011) · Aging · doi:10.18632/aging.100328 · Cited by 60
“Another study used additional medium supplements that included VEGF, and the Wnt inhibitor, Dickkopf homolog (DKK1), followed by the addition of bFGF, to promote cardiomyocyte differentiation from hEBs [52].”
BackgroundTakasato, M., & Little, M. H. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.08.024 · Cited by 46
“This multi-step approach to directed differentiation of hPSCs has successfully induced various cell types with high efficiency and quality, including haematopoietic, cardiac, pneumonic, pancreatic, hepatic, intestinal, cerebral and renal lineages (Davis et al., 2008; McCracken et al., 2011; Pagliuca et al., 2014; Taka…”
BackgroundDias, T. P., Pinto, S. N., Santos, J. I., Fernandes, T. G., Fernandes, F., Diogo, M. M., PRIETO, M. J. E., & Cabral, J. M. S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.198 · Cited by 49
Ruan, H., Liao, Y., Ren, Z., Mao, L., Yao, F., Yu, P., Ye, Y., Zhang, Z., Li, S., Xu, H., et al. (2019) · BMC Biology · doi:10.1186/s12915-019-0709-6 · Cited by 46
Toward the realization of cardiac regenerative medicine using pluripotent stem cells
Kishino, Y., Fujita, J., Tohyama, S., Okada, M., Tanosaki, S., Someya, S., & Fukuda, K. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-019-0110-4 · Cited by 48
Recent progress of iPSC technology in cardiac diseases
Funakoshi, S., & Yoshida, Y. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03172-3 · Cited by 52
“could differentiate cardiac mesoderm expressing KDR and PDGFRA into cardiomyocytes by manipulating BMP and activin A/ Nodal signaling at the early stage of the differentiation, followed by inhibition of the Wnt pathway (Yang et al. 2008).”
BackgroundIngeniería tisular cardiaca y corazón bioartificial
Gálvez‐Montón, C., Prat‐Vidal, C., Roura, S., Soler‐Botija, C., & Bayés‐Genís, A. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.11.013 · Cited by 52
Cardiac stem cells: Current knowledge and future prospects
Mehanna, R. A., Essawy, M. M., Barkat, M. A., Awaad, A. K., Thabet, E. H., Hamed, H. A., Elkafrawy, H., Khalil, N. A., Sallam, A., Kholief, M., et al. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i1.1 · Cited by 46
Cutts, J., Nikkhah, M., & Brafman, D. A. (2015) · Biomarker Insights · doi:10.4137/bmi.s20313 · Cited by 50
Apelin Enhances Directed Cardiac Differentiation of Mouse and Human Embryonic Stem Cells
Wang, I. E., Wang, X., Ge, X., Anderson, J. P., Ho, M. Y., Ashley, E. A., Liu, J., Butte, M. J., Yazawa, M., Dolmetsch, R. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038328 · Cited by 46
“. In a recently reported protocol, induction of hESCs with BMP-4, activin-A and basic fibroblast growth factor (bFGF) generated cardiac, endothelial and vascular smooth muscle cells”
BackgroundGe, X., Wang, I. E., Toma, I., Sebastiano, V., Liu, J., Butte, M. J., Pera, R. A. R., & Yang, P. C.-M. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0435 · Cited by 46
“In comparison to other published studies on the cardiac differentiation of iPSCs, MiPSC + s demonstrated a robust cardiac differentiation potential and generated an enriched pool of mature cardiac cells [1,8,24].”
ResultFacile formation of dynamic hydrogel microspheres for triggered growth factor delivery
King, W. J., Toepke, M. W., & Murphy, W. L. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.10.026 · Cited by 51
“First, hESCs were cultured in the absence of VEGF for 6 days, then VEGF was added to the culture media for 8 days to induce progenitor cell differentiation [4].”
BackgroundMethodChen, A., Lee, E., Tu, R., Santiago, K. C., Grosberg, A., Fowlkes, C. C., & Khine, M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.007 · Cited by 51
Yeghiazarians, Y., Gaur, M., Zhang, Y., Sievers, R. E., Ritner, C., Prasad, M., Boyle, A., & Bernstein, H. S. (2011) · Cytotherapy · doi:10.3109/14653249.2011.623690 · Cited by 46
The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells
Slukvin, I. I., & Kumar, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2871-3 · Cited by 49
“However, in contrast to MB colonies, cardiac colonies and cells expanded from these colonies express TBX5, TNX20, and MYL2 cardiac genes [53, 54].”
The march of pluripotent stem cells in cardiovascular regenerative medicine
Abou-Saleh, H., Zouein, F. A., EL‐Yazbi, A. F., Sanoudou, D., Raynaud, C. M., Rao, C., Pintus, G., Dehaini, H., & Eid, A. H. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0947-5 · Cited by 52
“In addition, other modulators such as Noggin [170], VEGF [148], CHIR and IWR-1/ IWP-2 [171, 172], TGF-β signaling inhibitor [173], and SHH signaling activation [173] have been shown to increase the differentiation efficiency.”
BackgroundNidogen‐1 Mitigates Ischemia and Promotes Tissue Survival and Regeneration
Zbinden, A., Layland, S. L., Urbanczyk, M., Berrio, D. A. C., Marzi, J., Zauner, M., Hammerschmidt, A., Brauchle, E., Sudrow, K., Fink, S., et al. (2020) · Advanced Science · doi:10.1002/advs.202002500 · Cited by 48
Heart organoids and tissue models for modeling development and disease
Miyamoto, M., Nam, L., Kannan, S., & Kwon, C. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2021.03.011 · Cited by 41
“…on this work, we utilized an updated differentiation protocol utilizing Bmp and Activin A (activating pathways necessary for mesodermal and cardiac differentiation[95,96]), to develop an EB sys-tem using fluorescent reporters of the FHF and SHF (Hcn4 and Tbx1, respectively) [23,97] (Table 1).”
Potential use of endothelial progenitor cells for regeneration of the vasculature
Yamahara, K., & Itoh, H. (2009) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708097728 · Cited by 50
Josowitz, R., Mulero-Navarro, S., Rodriguez, N. A., Falce, C., Cohen, N., Ullian, E. M., Weiss, L. A., Rauen, K. A., Sobie, E. A., & Gelb, B. D. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.07.018 · Cited by 45
“…and pluripotency was confirmed with immunofluorescence, gene expression, and tri-lineage differentiation assays (Figure S1). hiPSCs were differentiated along a cardiogenic lineage as 3D embryoid bodies (EBs) using a modification of an established protocol (Yang et al., 2008) (Figure 1B).”
MethodTorres, J., Prieto, J., Durupt, F. C., Broad, S., & Watt, F. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036405 · Cited by 45
Doyle, M. J., Lohr, J. L., Chapman, C. S., Koyano‐Nakagawa, N., Garry, M. G., & Garry, D. J. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9596-6 · Cited by 48
“When cultured as a monolayer, these cells generated more than 50 % CMs and when cultured under colony-forming conditions they generated CMs, endothelial cells and vascular smooth muscle cells [54].”
BackgroundBioengineering Approaches to Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes
Sun, X., & Nunes, S. S. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00019 · Cited by 46
“Cardiomyocytes can be differentiated from both hESCs and hiPSCs using directed differentiation approaches, which are based on the stage-specific treatment with cardiogenic-inducing signaling factors (Laflamme et al., 2007; Yang et al., 2008).”
Malandraki-Miller, S., Lopez, C. A., Al-Siddiqi, H., & Carr, C. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00119 · Cited by 53
Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects
Samak, M., & Hinkel, R. (2019) · Cells · doi:10.3390/cells8121530 · Cited by 47
“Nevertheless, differentiation of PSCs by using standard protocols usually yields a mixed population [118].”
BackgroundRole of resveratrol in inhibiting pathological cardiac remodeling
Fan, S., Hu, Y., You, Y., Xue, W., Chai, R., Zhang, X., Shou, X., & Shi, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924473 · Cited by 48
“CPCs have the potential to differentiate into various types of cardiomyocytes and can promote angiogenesis (Beltrami et al., 2003; Yang et al., 2008; Tallini et al., 2009).”
BackgroundCulture Conditions Affect Cardiac Differentiation Potential of Human Pluripotent Stem Cells
Ojala, M., Rajala, K., Pekkanen-Mattila, M., Miettinen, M., Huhtala, H., & Aalto‐Setälä, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048659 · Cited by 52
Metadata
- Authors
- Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Indiana University School of Medicine (US)
- Cornell University (US)
- University Health Network (CA)
- King's College London (GB)
- VistaGen Therapeutics (United States) (US)
- Corresponding author
- Keller, Gordon M.
- ORCID
- Venue
- Nature
- Published
- 2008-04-23
- Volume
- 453
- Issue
- 7194
- Pages
- 524-528
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2010417854
- Cited by
- 1,389
- References
- 30
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 33 · 2022: 45 · 2021: 60 · 2020: 65 · 2019: 59 · 2018: 66 · 2017: 89 · 2016: 79 · 2015: 107 · 2014: 114 · 2013: 141 · 2012: 146
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079275, R01HL083126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, cardiac progenitor cells, KDR, Flk-1, cardiomyocyte differentiation, endothelial differentiation, vascular smooth muscle cell differentiation, mesoderm specification, heart development, embryoid bodies, cell transplantation, cardiac regeneration, cardiovascular tissue engineering, lineage tracing, clonal origin, growth factor cocktail, activin A, BMP4, basic fibroblast growth factor
- MeSH terms
- Cell Differentiation, Cell Line, Humans, Fibroblast Growth Factor 2, Patch-Clamp Techniques, Proto-Oncogene Proteins c-kit, Cell Lineage, Bone Morphogenetic Proteins, Activins, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.